Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger
Condition: Severe Rotavirus GastroenteritisInterventions: Biological: Rotavirus vaccine (BRV-PV); Biological: PlaceboSponsors: Epicentre; Medecins Sans Frontieres; Serum Institute of India Limited; Forum Santé Niger; Ministry of Public Health Niger; Children's Hospital Medical Center, CincinnatiRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2014 Category: Research Source Type: clinical trials